"Given our role, the idea that distributors are responsible for the number of opioid prescriptions written defies common sense and lacks understanding of how the pharmaceutical supply chain actually works and is regulated," said senior vice president John Parker. "Those bringing lawsuits would be better served addressing the root causes, rather than trying to redirect blame through litigation."
"As an industry, we recognize the seriousness of the crisis and have advanced a comprehensive set of policy proposals to reduce overprescribing and address addiction as well as efforts to improve prevention and education," said John Parker, senior vice president at the alliance. "Further, distributors have invested substantially in the use of state-of-the-art tools to detect and prevent potential diversion. We will continue to work with policymakers to advance meaningful solutions to effectively address this epidemic."